Endocrine effects of new bombesin/gastrin-releasing peptide antagonists in rats

J. Pinski, T. Yano, K. Groot, R. Z. Cai, S. Radulovic, Andrew V Schally

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Four new and specific pseudononapeptide bombesin/gastrin-releasing peptide (GRP) receptor antagonists, containing the D-forms of Trp or Trp analogue (Tpi) at position 6, were studied for their effects on the endocrine pancreas and GRP-(14-27)-induced gastrin release in pentobarbital-anesthetized rats. One of the analogues, D-Tpi6,Leu13-ψ(CH2NH)Leu14-bombesin-(6-14) (RC- 3095), was injected into the lateral brain ventricle just preceding intracerebroventricular administration of GRP-(14-27) to evaluate its antagonistic effect on GRP-induced serum growth hormone (GH) suppression. Analogues RC-3095, D-Trp6,Leu13-ψ(CH2NH)Leu14-bombesin-(6-14) (RC- 3125), and D-Trp6,Leu13-ψ(CH2NH)Phe14-bombesin-(6-14) (RC-3420), but not D-Tpi6,Leu13-ψ(CH2NH)Phe14-bombesin-(6-14) (RC-3105), significantly (P < 0.01) inhibited GRP-(14-27)-stimulated serum gastrin secretion. Analogues RC-3095, RC-3420, and RC-3105, but not RC-3125, demonstrated significant (P < 0.05) antagonistic activities on GRP-(14-27)- stimulated plasma glucagon secretion. Intracerebroventricular injection of RC-3095 (10 μg) immediately before GRP-(14-27) (1 μg) completely prevented the GRP-(14-27)-induced serum GH suppression. These results indicate that 1) marked differences exist in the ability of these analogues to antagonize GRP- (14-27)-induced gastrin or glucagon release, suggesting the existence of different bombesin/GRP receptor subtypes, and 2) the central effect of bombesin/GRP on GH release from the pituitary is probably mediated through specific bombesin/GRP receptors.

Original languageEnglish
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume263
Issue number4 26-4
StatePublished - Jan 1 1992
Externally publishedYes

Fingerprint

Gastrin-Releasing Peptide
Bombesin
Rats
Bombesin Receptors
Gastrins
Growth Hormone
Glucagon
Serum
Lateral Ventricles
Pentobarbital
gastrin releasing peptide (14-27)
Islets of Langerhans
Brain
Plasmas
Injections
Tpi(6)-Leu(13)-psi(CH2NH)-Leu(14)-bombesin (6-14)

Keywords

  • endocrine pancreas
  • receptor

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Physiology

Cite this

Endocrine effects of new bombesin/gastrin-releasing peptide antagonists in rats. / Pinski, J.; Yano, T.; Groot, K.; Cai, R. Z.; Radulovic, S.; Schally, Andrew V.

In: American Journal of Physiology - Endocrinology and Metabolism, Vol. 263, No. 4 26-4, 01.01.1992.

Research output: Contribution to journalArticle

@article{615d229293ce441383acd83eaa58ebb0,
title = "Endocrine effects of new bombesin/gastrin-releasing peptide antagonists in rats",
abstract = "Four new and specific pseudononapeptide bombesin/gastrin-releasing peptide (GRP) receptor antagonists, containing the D-forms of Trp or Trp analogue (Tpi) at position 6, were studied for their effects on the endocrine pancreas and GRP-(14-27)-induced gastrin release in pentobarbital-anesthetized rats. One of the analogues, D-Tpi6,Leu13-ψ(CH2NH)Leu14-bombesin-(6-14) (RC- 3095), was injected into the lateral brain ventricle just preceding intracerebroventricular administration of GRP-(14-27) to evaluate its antagonistic effect on GRP-induced serum growth hormone (GH) suppression. Analogues RC-3095, D-Trp6,Leu13-ψ(CH2NH)Leu14-bombesin-(6-14) (RC- 3125), and D-Trp6,Leu13-ψ(CH2NH)Phe14-bombesin-(6-14) (RC-3420), but not D-Tpi6,Leu13-ψ(CH2NH)Phe14-bombesin-(6-14) (RC-3105), significantly (P < 0.01) inhibited GRP-(14-27)-stimulated serum gastrin secretion. Analogues RC-3095, RC-3420, and RC-3105, but not RC-3125, demonstrated significant (P < 0.05) antagonistic activities on GRP-(14-27)- stimulated plasma glucagon secretion. Intracerebroventricular injection of RC-3095 (10 μg) immediately before GRP-(14-27) (1 μg) completely prevented the GRP-(14-27)-induced serum GH suppression. These results indicate that 1) marked differences exist in the ability of these analogues to antagonize GRP- (14-27)-induced gastrin or glucagon release, suggesting the existence of different bombesin/GRP receptor subtypes, and 2) the central effect of bombesin/GRP on GH release from the pituitary is probably mediated through specific bombesin/GRP receptors.",
keywords = "endocrine pancreas, receptor",
author = "J. Pinski and T. Yano and K. Groot and Cai, {R. Z.} and S. Radulovic and Schally, {Andrew V}",
year = "1992",
month = "1",
day = "1",
language = "English",
volume = "263",
journal = "American Journal of Physiology - Cell Physiology",
issn = "0363-6143",
publisher = "American Physiological Society",
number = "4 26-4",

}

TY - JOUR

T1 - Endocrine effects of new bombesin/gastrin-releasing peptide antagonists in rats

AU - Pinski, J.

AU - Yano, T.

AU - Groot, K.

AU - Cai, R. Z.

AU - Radulovic, S.

AU - Schally, Andrew V

PY - 1992/1/1

Y1 - 1992/1/1

N2 - Four new and specific pseudononapeptide bombesin/gastrin-releasing peptide (GRP) receptor antagonists, containing the D-forms of Trp or Trp analogue (Tpi) at position 6, were studied for their effects on the endocrine pancreas and GRP-(14-27)-induced gastrin release in pentobarbital-anesthetized rats. One of the analogues, D-Tpi6,Leu13-ψ(CH2NH)Leu14-bombesin-(6-14) (RC- 3095), was injected into the lateral brain ventricle just preceding intracerebroventricular administration of GRP-(14-27) to evaluate its antagonistic effect on GRP-induced serum growth hormone (GH) suppression. Analogues RC-3095, D-Trp6,Leu13-ψ(CH2NH)Leu14-bombesin-(6-14) (RC- 3125), and D-Trp6,Leu13-ψ(CH2NH)Phe14-bombesin-(6-14) (RC-3420), but not D-Tpi6,Leu13-ψ(CH2NH)Phe14-bombesin-(6-14) (RC-3105), significantly (P < 0.01) inhibited GRP-(14-27)-stimulated serum gastrin secretion. Analogues RC-3095, RC-3420, and RC-3105, but not RC-3125, demonstrated significant (P < 0.05) antagonistic activities on GRP-(14-27)- stimulated plasma glucagon secretion. Intracerebroventricular injection of RC-3095 (10 μg) immediately before GRP-(14-27) (1 μg) completely prevented the GRP-(14-27)-induced serum GH suppression. These results indicate that 1) marked differences exist in the ability of these analogues to antagonize GRP- (14-27)-induced gastrin or glucagon release, suggesting the existence of different bombesin/GRP receptor subtypes, and 2) the central effect of bombesin/GRP on GH release from the pituitary is probably mediated through specific bombesin/GRP receptors.

AB - Four new and specific pseudononapeptide bombesin/gastrin-releasing peptide (GRP) receptor antagonists, containing the D-forms of Trp or Trp analogue (Tpi) at position 6, were studied for their effects on the endocrine pancreas and GRP-(14-27)-induced gastrin release in pentobarbital-anesthetized rats. One of the analogues, D-Tpi6,Leu13-ψ(CH2NH)Leu14-bombesin-(6-14) (RC- 3095), was injected into the lateral brain ventricle just preceding intracerebroventricular administration of GRP-(14-27) to evaluate its antagonistic effect on GRP-induced serum growth hormone (GH) suppression. Analogues RC-3095, D-Trp6,Leu13-ψ(CH2NH)Leu14-bombesin-(6-14) (RC- 3125), and D-Trp6,Leu13-ψ(CH2NH)Phe14-bombesin-(6-14) (RC-3420), but not D-Tpi6,Leu13-ψ(CH2NH)Phe14-bombesin-(6-14) (RC-3105), significantly (P < 0.01) inhibited GRP-(14-27)-stimulated serum gastrin secretion. Analogues RC-3095, RC-3420, and RC-3105, but not RC-3125, demonstrated significant (P < 0.05) antagonistic activities on GRP-(14-27)- stimulated plasma glucagon secretion. Intracerebroventricular injection of RC-3095 (10 μg) immediately before GRP-(14-27) (1 μg) completely prevented the GRP-(14-27)-induced serum GH suppression. These results indicate that 1) marked differences exist in the ability of these analogues to antagonize GRP- (14-27)-induced gastrin or glucagon release, suggesting the existence of different bombesin/GRP receptor subtypes, and 2) the central effect of bombesin/GRP on GH release from the pituitary is probably mediated through specific bombesin/GRP receptors.

KW - endocrine pancreas

KW - receptor

UR - http://www.scopus.com/inward/record.url?scp=0026785223&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026785223&partnerID=8YFLogxK

M3 - Article

C2 - 1415689

AN - SCOPUS:0026785223

VL - 263

JO - American Journal of Physiology - Cell Physiology

JF - American Journal of Physiology - Cell Physiology

SN - 0363-6143

IS - 4 26-4

ER -